Wang et al. [30] have demonstrated that Ki67 and glypican are significant markers for predicting the biological behavior of HCC, and proposed that glypican may serve as a crucial target for immunotherapy in HCC. This evidence concerns the gene MKI67 and hepatocellular carcinoma.